More
    Guided Solutions - Connecting Talent With Innovation/div>

    Ohio State University launches first-in-world clinical trial of heart failure device

    The Ohio State University Wexner Medical Center on Wednesday randomized the first patient in the world in a clinical trial evaluating the effectiveness of...

    UroMems completes first-in-human study enrollment for smart urinary implant

    UroMems announced today that it successfully completed enrollment in its first-in-human study of its UroActive system. Grenoble, France-based UroMems designed the UroActiv system as a smart,...

    New device can help test treatments in patients with gliomas

    The shape and size of a grain of rice, the new device can conduct dozens of experiments at once to study the effects of...

    Synchron Completes Patient Enrollment for COMMAND Trial of Brain Computer Interface

    Synchron, the endovascular brain-computer interface (BCI) company developing technology to restore functionality in patients with severe paralysis, announced completion of patient enrollment in the...

    Noah Medical Unveils Preliminary First In-Human Trial Results at AABIP 2023

    Noah Medical has announced that it presented new data demonstrating the navigational success and safety of its Galaxy System from the platform’s first in-human trial....

    Overland Park Regional Medical Center Completes First Procedures Using Stereotaxis Genesis Robotic System

    Stereotaxis has announced that physicians at Overland Park Regional Medical Center (OPRMC) launched and successfully completed the first procedures using the advanced Genesis Robotic Magnetic Navigation (RMN)...

    Cydar Medical Announces First Patient Treated in Global Strategic Collaboration with Medtronic

    Cydar Medical announces the successful treatment of the first patient in a strategic collaboration with Medtronic, a global leader in medical technology, services and solutions....

    GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care

    GE HealthCare (Nasdaq: GEHC) announces the launch of CardioVisio for Atrial Fibrillation (AFib), a digital tool designed to assist clinicians in visualizing longitudinal data...

    New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Elderly Patients Undergoing Gastrointestinal Surgery

    Researchers Found That Fluid Therapy Guided by Noninvasive, Continuous PVi Reduced Cardiopulmonary Complications and Fluid Administered Masimo (NASDAQ: MASI) announced the findings of a prospective, randomized...

    Latest articles